Zydus, Pinkathon to drive awareness on breast cancer across India
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
No post-injection Delirium/Sedation Syndrome (PDSS) observed through 56 weeks
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
This predictive technology empowers people with diabetes to take preventive action before complications arise
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
Encouraging early detection and breaking the silence around men’s health
IND application for EB-003 expected in early 2026
Subscribe To Our Newsletter & Stay Updated